Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
Desselle A, Chaumette T, Gaugler MH, Cochonneau D, Fleurence J, Dubois N, Hulin P, Aubry J, Birklé S, Paris F. Desselle A, et al. PLoS One. 2012;7(11):e45423. doi: 10.1371/journal.pone.0045423. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189121 Free PMC article.
Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting.
Birklé S, Desselle A, Chaumette T, Gaugler MH, Cochonneau D, Fleurence J, Dubois N, Hulin P, Aubry J, Paris F. Birklé S, et al. Among authors: desselle a. Oncoimmunology. 2013 Apr 1;2(4):e23700. doi: 10.4161/onci.23700. Oncoimmunology. 2013. PMID: 23734323 Free PMC article.
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
Alvarez-Rueda N, Desselle A, Cochonneau D, Chaumette T, Clemenceau B, Leprieur S, Bougras G, Supiot S, Mussini JM, Barbet J, Saba J, Paris F, Aubry J, Birklé S. Alvarez-Rueda N, et al. Among authors: desselle a. PLoS One. 2011;6(9):e25220. doi: 10.1371/journal.pone.0025220. Epub 2011 Sep 22. PLoS One. 2011. PMID: 21966461 Free PMC article.